OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 2.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 136,234 shares of the company’s stock after acquiring an additional 3,800 shares during the period. Charles Schwab Investment Management Inc.’s holdings in OrthoPediatrics were worth $3,158,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Wellington Management Group LLP lifted its stake in shares of OrthoPediatrics by 16.2% in the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after purchasing an additional 122,846 shares during the last quarter. Barclays PLC raised its holdings in OrthoPediatrics by 319.3% in the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock valued at $686,000 after buying an additional 19,264 shares during the period. Geode Capital Management LLC raised its holdings in OrthoPediatrics by 2.1% in the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after buying an additional 7,972 shares during the period. BNP Paribas Financial Markets lifted its position in OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after buying an additional 1,929 shares during the last quarter. Finally, Centiva Capital LP purchased a new position in OrthoPediatrics during the third quarter worth about $319,000. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Trading Up 1.4 %

NASDAQ KIDS opened at $24.75 on Friday. OrthoPediatrics Corp. has a one year low of $21.02 and a one year high of $35.99. The firm has a 50 day simple moving average of $24.80 and a 200-day simple moving average of $25.32. The firm has a market cap of $601.10 million, a price-to-earnings ratio of -20.12 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analyst estimates of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same period last year, the business earned ($0.23) EPS. Equities research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Insider Buying and Selling

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 5,310 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $132,006.60. Following the completion of the sale, the general counsel now directly owns 110,767 shares of the company’s stock, valued at $2,753,667.62. This represents a 4.57 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Fred Hite sold 6,443 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $160,172.98. Following the sale, the chief financial officer now directly owns 207,989 shares of the company’s stock, valued at $5,170,606.54. The trade was a 3.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 23,732 shares of company stock worth $589,978 in the last ninety days. 31.80% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on KIDS shares. Truist Financial decreased their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Stifel Nicolaus decreased their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Wednesday, March 5th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research report on Wednesday, March 5th.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.